New data on ADHD study drug NS2359

By |2016-10-05T06:46:13-04:00June 25th, 2008|Categories: ADHD, Medication, Research|Tags: , , , , , , , |

NS2359 is a mixed monoamine reuptake inhibitor.  A study looked at the efficacy of NS2359 versus placebo in a double-blind randomized trial. There was no statistical difference in the total ADHD-RS scale score between those taking NS2359 and placebo.  However, when looking at the inattentive type of ADHD, 41% of those who took NS2359 had an [...]

Comments Off on New data on ADHD study drug NS2359
Go to Top